116 related articles for article (PubMed ID: 16838132)
1. Mutational analysis of human BLyS in patients with common variable immunodeficiency.
Losi CG; Salzer U; Gatta R; Lougaris V; Cattaneo G; Meini A; Soresina A; Grimbacher B; Plebani A
J Clin Immunol; 2006 Jul; 26(4):396-9. PubMed ID: 16838132
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency.
Losi CG; Silini A; Fiorini C; Soresina A; Meini A; Ferrari S; Notarangelo LD; Lougaris V; Plebani A
J Clin Immunol; 2005 Sep; 25(5):496-502. PubMed ID: 16160919
[TBL] [Abstract][Full Text] [Related]
3. B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro.
Stewart DM; McAvoy MJ; Hilbert DM; Nelson DL
Clin Immunol; 2003 Nov; 109(2):137-43. PubMed ID: 14597212
[TBL] [Abstract][Full Text] [Related]
4. Age-related changes in BAFF and APRIL profiles and upregulation of BAFF and APRIL expression in patients with primary antibody deficiency.
Jin R; Kaneko H; Suzuki H; Arai T; Teramoto T; Fukao T; Kondo N
Int J Mol Med; 2008 Feb; 21(2):233-8. PubMed ID: 18204790
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of common variable immunodeficiency.
Castigli E; Geha RS
J Allergy Clin Immunol; 2006 Apr; 117(4):740-6; quiz 747. PubMed ID: 16630927
[TBL] [Abstract][Full Text] [Related]
6. TACI mutation with invasive polyclonal CD8+ T-cell lymphoproliferation in a patient with common variable immunodeficiency.
Berglund LJ; Jones GJ; Murali R; Fulcher DA
J Allergy Clin Immunol; 2006 Apr; 117(4):870-7. PubMed ID: 16630947
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of CARMA1/CARD11 and Bob1 as candidate genes in common variable immunodeficiency.
Tampella G; Baronio M; Vitali M; Soresina A; Badolato R; Giliani S; Plebani A; Lougaris V
J Investig Allergol Clin Immunol; 2011; 21(5):348-53. PubMed ID: 21905497
[TBL] [Abstract][Full Text] [Related]
8. Mutation in IRF2BP2 is responsible for a familial form of common variable immunodeficiency disorder.
Keller MD; Pandey R; Li D; Glessner J; Tian L; Henrickson SE; Chinn IK; Monaco-Shawver L; Heimall J; Hou C; Otieno FG; Jyonouchi S; Calabrese L; van Montfrans J; Orange JS; Hakonarson H
J Allergy Clin Immunol; 2016 Aug; 138(2):544-550.e4. PubMed ID: 27016798
[TBL] [Abstract][Full Text] [Related]
9. High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency.
Knight AK; Radigan L; Marron T; Langs A; Zhang L; Cunningham-Rundles C
Clin Immunol; 2007 Aug; 124(2):182-9. PubMed ID: 17556024
[TBL] [Abstract][Full Text] [Related]
10. TACI is mutant in common variable immunodeficiency and IgA deficiency.
Castigli E; Wilson SA; Garibyan L; Rachid R; Bonilla F; Schneider L; Geha RS
Nat Genet; 2005 Aug; 37(8):829-34. PubMed ID: 16007086
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
Lee JJ; Ozcan E; Rauter I; Geha RS
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
[TBL] [Abstract][Full Text] [Related]
12. Analysis of genetic defects in patients with the common variable immunodeficiency phenotype in a single Taiwanese tertiary care hospital.
Lee WI; Huang JL; Kuo ML; Lin SJ; Chen LC; Chen MT; Jaing TH
Ann Allergy Asthma Immunol; 2007 Nov; 99(5):433-42. PubMed ID: 18051214
[TBL] [Abstract][Full Text] [Related]
13. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans.
Salzer U; Chapel HM; Webster AD; Pan-Hammarström Q; Schmitt-Graeff A; Schlesier M; Peter HH; Rockstroh JK; Schneider P; Schäffer AA; Hammarström L; Grimbacher B
Nat Genet; 2005 Aug; 37(8):820-8. PubMed ID: 16007087
[TBL] [Abstract][Full Text] [Related]
14. A novel compound heterozygous TACI mutation in an autosomal recessive common variable immunodeficiency (CVID) family.
Lougaris V; Gallizzi R; Vitali M; Baronio M; Salpietro A; Bergbreiter A; Salzer U; Badolato R; Plebani A
Hum Immunol; 2012 Aug; 73(8):836-9. PubMed ID: 22627058
[TBL] [Abstract][Full Text] [Related]
15. Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas.
Fu L; Lin-Lee YC; Pham LV; Tamayo A; Yoshimura L; Ford RJ
Blood; 2006 Jun; 107(11):4540-8. PubMed ID: 16497967
[TBL] [Abstract][Full Text] [Related]
16. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
17. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome.
Novak AJ; Grote DM; Stenson M; Ziesmer SC; Witzig TE; Habermann TM; Harder B; Ristow KM; Bram RJ; Jelinek DF; Gross JA; Ansell SM
Blood; 2004 Oct; 104(8):2247-53. PubMed ID: 15251985
[TBL] [Abstract][Full Text] [Related]
18. Effect of TACI signaling on humoral immunity and autoimmune diseases.
Zhang Y; Li J; Zhang YM; Zhang XM; Tao J
J Immunol Res; 2015; 2015():247426. PubMed ID: 25866827
[TBL] [Abstract][Full Text] [Related]
19. Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis.
Kawasaki A; Tsuchiya N; Fukazawa T; Hashimoto H; Tokunaga K
Genes Immun; 2002 Nov; 3(7):424-9. PubMed ID: 12424625
[TBL] [Abstract][Full Text] [Related]
20. BLyS--an essential survival factor for B cells: basic biology, links to pathology and therapeutic target.
Baker KP
Autoimmun Rev; 2004 Jul; 3(5):368-75. PubMed ID: 15288003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
